DNA Script Raises $38.5 Million in Series B Financing

Funding & investments

Home » Funding & investments » Page 2

Dyadic Announces Uplisting to the Nasdaq Capital Market

Azitra Receives Ongoing Support for Its Netherton Development Program from the National Science Foundation (NSF)

2019 Q1 report companies

Meet the 25 synthetic biology companies that raised $652M this quarter

Kevin Ness Inscripta

Inscripta adds $20M to its $105M Series C to create CRISPR-powered gene editing tools

Synthetic biology’s latest unicorn Mammuty closes $100M Series A for cell-based meats from extinct animals

Meissa Vaccines Closes $3.4 Million Financing to Advance RSV Vaccine to Clinic

Sherlock Biosciences

Sherlock Biosciences Launches to Provide Better, Faster and More Affordable Diagnostic Testing Worldwide Through Engineering Biology

Yield10 Bioscience Announces Pricing of $2.9 Million Registered Direct Offering

Beam Therapeutics Secures $135 Million in Series B Financing to Advance Base Editing Platform and Expand Pipeline of Precision Genetic Medicines

The Next Industrial Revolution: Computational biology & bioplatforms